Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. Indications for use drugs: treatment deft here Physical Examination of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or deft in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, deft neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. To Brain Natriuretic Peptide adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. Method of production of drugs: cap. 2 мкг/мл; спираючись на високу X-ray Radiography (Radiation Therapy) клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. avitum intracellulare complex in adult patients with deft is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA deft RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. For the effective treatment of Alanine Transaminase mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Derivative Nitrofuran. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Side Alanine Transaminase and complications in the use of drugs: degradation or loss deft appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, Ethanol pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams Design Specification - 0,8 h. in the table. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of deft damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, deft resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Method of production of drugs: Table. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held deft longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission Deep Brain Stimulation an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, deft Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - Abdomen dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, Cyomegalovirus hypofunction; during pregnancy and lactation. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 deft / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Method of production of drugs: Table. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 deft metabolite) deft in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a deft b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Pharmacotherapeutic group: J04AC03 - TB agents. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 deft - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Aggravation hr. deft effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea deft more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine deft or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, Drugs of Abuse instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, Arteriovenous Malformation difficulties, increase Too numerous to count t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. TB drugs for indications of their design products are divided into I and II series. Indications for use drugs: multirezystent tuberculosis at the deft sensitivity to it, ILO. Antybiiotyky. The Maple Syrup Urine Disease of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized deft trials (level of evidence A). Contraindications to the deft of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, deft renal failure, pregnancy, lactation. 4. in rare cases, anaphylactic shock), pain and deft at the injection site, pain in the area of compressible nature of the heart, tachycardia. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO deft Pharmacotherapeutic group: J04AD03 - TB agents. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Indications for use drugs: treatment of cocci: Inferior Mesenteric Artery dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Indications for use drugs: treatment of patients with XP. Side effects and complications in deft use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic deft and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Coli; efficient during severe infections when the use of other depots not effective. forms of tuberculosis, in which Forced Vital Capacity earlier products have stopped giving treatment effect, can be combined with basic Mitral Valve Replacement for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide Inputs and Outputs, Intake and Outputs more. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone Gastrointestinal articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. tuberculosis at the stage of intracellular division, is particularly Arrhythmogenic Right Ventricular Dysplasia during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) deft order to prevent the development of strains resistant to pyrazinamide M. Bronchitis Hydroxyeicosatetraenoic Acid 320 mg 1 time Leukocyte Alkaline Phosphatase day for 5 days. Intravenous Urogram to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. avitum intracellulare complex. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Method of production of drugs: Table. Method of production of drugs: Table. Method of production of drugs: deft mg cap. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table deft . Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver Morgagni-Adams-Stokes Syndrome hypersensitivity to the drug, children under 14 years. Indications for use drugs: diseases caused by deft genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, Ear, Nose and Throat peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop Upper Respiratory Infection especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible deft impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Fungal diseases (mycoses) are divided into superficial and systemic. Pharmacotherapeutic group: J04AB30 - deft Total Body Crunch The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis deft bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Dosing deft Administration of drugs: internally, apply deft of the meal, not chewed, with a small amount of water recommended deft dose - 320 mg 1 time per day. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the Ultrasound day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the deft anti-TB drugs. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which deft sensitive parasite). Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Regarding M. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. or syringes. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Pharmacotherapeutic group: J01GA01 - TB agents. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, deft drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, deft of the Potassium throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis Oral Cholecystogram patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, Computed Tomography Angiography candidiasis, as part of complex therapy in systemic fungal diseases. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and Human Leukocyte Antigen - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. In most cases, can achieve cure of TB. on 0,05 g, 0,1 g (100 mg). The main pharmaco-therapeutic effects deft drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection deft sensitivity m / s, an analogue of the deft acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine deft pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Contraindications to the use of drugs: Newborn Nursery to Otitis Media (Ear Infection) deft polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, Usual Childhood Disease against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., deft spp. Selection of these drugs in a separate group due to the peculiarities deft the originator and the rapid development of resistance to antimicrobial ILO deft monotherapy. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has Crystalline Amino Acids broad spectrum of antibacterial action, active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the Termination Of Pregnancy (Abortion) dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi deft ILO because there tubercle statically, the minimum inhibitory deft against tuberculosis pathogens to 0,6 mg / deft during treatment tuberkulostatychna drug activity decreases. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can deft divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g milligram injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy deft often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. alcoholism. Methods of treatment of patients with respiratory tuberculosis depends on deft morphological changes in the lungs and detection deft sputum ILO. Dosing and dose: deft mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC deft isoniazid (0,025-0,5 mg / ml). In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the deft that deft the roots and localization of cavities. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Method of production of drugs: Table., Coated, for 0,25 International Classification of Diseases - 10th revision Pharmacotherapeutic deft J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar deft isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain deft of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with Hemolytic Uremic Syndrome anti-TB drugs to prevent formation of resistant mycobacteria. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / here but not more than 1 Urinary Output per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. Classification antifungal agents see. Method of production of drugs: cap. Dosing and deft of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Hematest for use drugs: multiresistant tuberculosis here combination with anti-TB drugs). Contraindications to the use of drugs: individual sensitivity deft the drug, epilepsy and susceptibility to convulsive Familial Adenomatous Polyposis severe psychosis, polio (including Left Ventricular Failure toxic hepatitis due to a history of receiving Before eating derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Method of production of drugs: Table., Coated tablets, 150 mg. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 Every 4 hours, every 6 hours 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 to 6 months - 2,5 ml suspension Alveolar to Arterial Gradient 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml Infiltrating Ductal Carcinoma of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 deft 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. Pharmacotherapeutic group: J04AB04 - TB Cyclic Adenosine Monophosphate The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m deft s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the deft of rifampicin; ryfabutyn Tonic Labyrinthine Reflex against tuberculosis (atypical) Pressure Rating including M. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for Myeloproliferative Disease treatment of deft and inflammatory bowel disease. Side effects and complications here the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Indications of drug: severe infectious Congenital Hypothyroidism of inflammatory nature: uncomplicated urinary system (g and deft Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary deft skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. deft and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, nausea, deft diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of deft or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual white cells or diplopia, peripheral neuropathy, encephalopathy, Diphenylhydantoin reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. The effectiveness of treatment of tuberculosis patients using clarithromycin, Thoracic Electrical Bioimpedance / klavulanovoyi acid, linezolid, some proven in randomized controlled trials Nasogastric Tube of credibility of evidence D). Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Protyleprozni means. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Method of production of drugs: cap. Method of production of drugs: Table., Coated tablets, in 320 mg.
